House Ways and Means Committee Chairman Kevin Brady (R-Texas) is rejecting an important piece of Donald Trump's healthcare plan proposal, according to The Hill.
Here are four notes:
1. Rep. Brady said he will not back Mr. Trump's plan to allow Medicare to negotiate prices for pharmaceuticals.
2. The proposal to allow Medicare to negotiate drug prices has long been a part of Democratic healthcare platforms.
3. Rep. Brady said that allowing this proposal would limit access since drugs that are more expensive, but also more effective, may be rejected.
4. Rep. Brady also said studies have shown the proposal would not save money.